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Nanodiamonds are of interest as nontoxic substrates for targeted drug delivery and as highly
biostable fluorescent markers for cellular tracking. Beyond optical techniques however, options for
noninvasive imaging of nanodiamonds in vivo are severely limited. Here, we demonstrate that the
Overhauser effect, a proton-electron double resonance technique developed to detect free radicals
in vivo, can enable high contrast magnetic resonance imaging (MRI) of nanodiamonds in water
at room temperature and ultra-low magnetic field. The technique transfers spin polarization from
paramagnetic impurities at nanodiamond surfaces to 1H spins in the surrounding water solution,
creating MRI contrast on-demand. We further examine the conditions required for maximum en-
hancement as well as the ultimate sensitivity of the technique. The ability to perform continuous
hyperpolarization via the Overhauser mechanism, in combination with excellent in vivo stability,
raises the possibility of performing noninvasive tracking of nanodiamonds over indefinitely long
periods of time.
Nanoparticles are rapidly emerging as powerful thera-
nostic substrates [1] for the targeted delivery of vaccines
[2], chemotherapy agents [3], immunotheraputics [4] and
as a means of tracking tumor distribution on whole-body
scales [5, 6]. Biocompatible nanodiamonds (NDs) are
ideal examples, featuring surfaces that are readily func-
tionalized to enable tissue growth and their selective up-
take by disease processes [7–10]. Imaging NDs in vivo,
however, has been to date, mostly limited to sub-cellular
environments that are optically accessible [11, 12]. With-
out imaging modalities beyond optical florescence, real-
ization of the full theranostic potential of ND to track and
investigate complex disease processes, such as metastatic
disease, is unlikely.
Magnetic resonance imaging (MRI) is the gold stan-
dard for noninvasive high-contrast imaging of disease in
radiology, but has proven ineffective for directly detect-
ing NDs in vivo due to the low abundance and small gy-
romagnetic ratio of spin-active 13C nuclei that comprise
the carbon lattice. Hyperpolarization of the 13C nuclei
at cryogenic temperatures can, in principle, overcome the
inherently weak signal from diamond by boosting it some
10,000 times to enable MRI contrast from nanoparticle
compounds [13–15]. Despite these prospects, hyperpolar-
ized nuclei always relax to their thermal polarization in
a time that, for the smaller sub-micron particles, is cur-
rently short enough to limit the usefulness of the method
in an imaging context [13, 16].
An alternative approach to tracking concentrations of
ND involves functionalizing the ND surface with param-
agnetic Gd(III)-chelates to create complexes that could
potentially be imaged in vivo with conventional T1-
weighted MRI [17]. However, this approach faces the
challenges of a large background signal and concerns over
the potential toxicity of gadolinium-based compounds in
the long term [18].
Here, we demonstrate a viable means of imaging and
tracking water-ND solutions in vivo using Overhauser
magnetic resonance imaging (OMRI) [19–22]. Operation
at ultra-low magnetic field (ULF) enables efficient and
biocompatible Overhauser polarization transfer between
electronic and nuclear spins. RF pulsing of the electron
paramagnetic resonance (EPR) transition between MRI
signal acquisitions continually transfers spin polarization
from the paramagnetic centers at the surface of ND to 1H
nuclei in the surrounding water [23]. The presence of ND
in the solution thus leads to an enhancement in the 1H
MRI signal that can readily produce images with contrast
sensitive to ND concentrations. Our approach overcomes
the limitations imposed by short spin relaxation times of
smaller particles and enables switchable tracking of ND
solutions over indefinite timescales. In addition to pro-
ducing images to demonstrate the approach, we inves-
tigate the conditions under which this technique leads
to maximum sensitivity to the presence of ND, present-
ing data characterising the efficiency of the Overhauser
mechanism as a function of particle concentration and
size. These results significantly enhance the theranostic
capabilities of non-toxic, bio-functionalized ND, opening
the possibility that MRI can be used to monitor and track
ND-compounds in vivo.
THE OVERHAUSER EFFECT IN
NANODIAMOND SOLUTIONS
Various types of ND were used in this study, includ-
ing high-pressure, high-temperature (HPHT), natural
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2(NAT) and detonation (DET) NDs in sizes from 4 nm
- 125 nm. We focus on results obtained from HPHT 18
nm and HPHT 125 nm NDs as typical representatives of
the general behaviour observed. An air oxidization pro-
cess, known to etch the ND surface, produces additional
variants of NDs for comparison with the commercially
sourced varieties [24]. Aqueous solutions of ND in deion-
ized (DI) water were prepared using high power probe
sonication, with HPHT NDs exhibiting the most stability
in solution. HPHT 125 nm solutions show no aggrega-
tion over a period of months and a zeta potential of -55
mV [see methods for further details on ND preparation].
The basis for detecting and imaging ND in solution is
shown in Fig. 1(a). Image contrast arises from the Over-
hauser effect, which as a starting point, requires a reser-
voir of partially polarized electron spins [25]. Driving
these electrons with a resonant ac magnetic field transfers
spin polarization to the interacting 1H nuclei in the sur-
rounding solution, (see Fig. 1(a)) [26, 27]. NDs provide
such a reservoir in the form of paramagnetic impurities
such as nitrogen vacancy centers, substitutional nitrogen
(P1) centers, and unpaired electrons at the nanoparti-
cle surface [28, 29]. We first characterize our NDs using
EPR spectroscopy, determining their impurity content
and suitability for Overhauser imaging.
The EPR spectra of our HPHT 18 nm ND solution is
shown in Fig. 1(b) and fits a two-component spin-1/2
model comprising a broad (1.2 mT) component and a
narrow (0.2 mT) component (solid lines in figure) [30].
Air oxidation of NDs reduces the amplitude of the broad
component in the spectra, presumably by removing the
paramagnetic centers at the surface. Our results are con-
sistent with previous studies suggesting that the broad
component is due to disordered dangling bonds at the
surface of the ND with the narrow component arising
from lattice defects in the crystalline core [31]. Other
types of ND studied here demonstrate similar spectral
components [see SI for further details].
Having established that ND provides a paramagnetic
reservoir suitable for the Overhauser effect, we turn now
to address the additional conditions that must be satis-
fied to enable imaging. Given the ensemble average of
the z-component of the nuclear spin over the nuclear mo-
ment, the enhancement,  = 〈Iz〉 /I0, generated by the
Overhauser mechanism is a function of four parameters
[32]:
 = 1− ρfs |γe|
γn
(1)
where ρ is the coupling factor between electron and nu-
clear spins, f the leakage factor, s the saturation factor,
and γe and γn are the electron and nuclear gyromagnetic
ratios. Addressing first the coupling factor ρ, we note
that, when there is dipolar coupling but no hyperfine con-
tact interaction between spins, ρ takes a positive value
determined by the correlation time of the two spins, diffu-
sion coefficients and the EPR frequency. Relatively long
FIG. 1. (a) Schematic of the Overhauser effect at the ND-
water interface. (b) X-band EPR spectra of NDs in 100
mg·mL−1 solutions of DI water. The left panel shows the
spectrum of HPHT 18 nm NDs (blue) and the right panel
shows the spectrum of the same HPHT 18 nm NDs after
air oxidation (orange). Both EPR spectra are fitted with
a two-spin model (dark blue) that is the sum of a broad
spin-1/2 component (green) and a narrow spin-1/2 compo-
nent (brown). Air oxidation is seen to remove the broad com-
ponent whilst leaving the narrow component relatively unaf-
fected. (c) Zeeman split electron and nuclear spin levels in a
magnetic field. Zero-quantum (w0), single-quantum (w1) and
double-quantum transitions (w2) are shown. If the w2 tran-
sition dominates, when the EPR transition is pumped, there
is a net movement to the |↓e↓1H〉 state. (d) Coupling factor ρ
as a function of magnetic field for a translational correlation
time (τc) of 430 ns.
correlation times are expected at ND surfaces due to the
formation of a nanophase of water with 1 nm thickness
at the ND-water interface [33]. Assuming free diffusion
of water at a distance of 1 nm from the ND surface, we
follow refs. [34–37] and plot the field dependence of ρ for
a calculated correlation time of 430 ns, as shown in Fig.
1(d) [see SI for details of calculation]. Not surprisingly,
given the long correlation time between spins, increasing
the magnetic field above a few milli-Tesla rapidly sup-
3presses the mutual flip-flip of dipolar coupled electron
and nuclear spins and thus the nuclear enhancement pos-
sible via the Overhauser effect. Our choice of magnetic
field for Overhauser imaging is thus constrained to the
ULF regime, where serendipitously, the frequency of the
EPR field produces minimal heating from dielectric loss
associated with water at 20◦C [38].
FIG. 2. (a) Overhauser enhancement of 1H polarization in
an HPHT 125 nm 100 mg·mL−1 ND solution. The DNP 1H
spectrum (red) is enhanced by -4.0 over the thermal 1H spec-
trum (blue). The enhanced spectrum was acquired after the
EPR transition had been driven for 1.5 s with 49 W of RF
power at 190 MHz. (b) 1H saturation enhancement vs con-
centration for ND solutions at 49 W, 6.5 mT and 190 MHz.
The Overhauser effect was observed for HPHT (blue - 18 nm,
yellow - 125 nm), NAT 125 nm (green), DET (red) and air
oxidized HPHT 18 nm NDs (orange). Solid lines are included
as a guide to the eye. Arrow indicates the change in enhance-
ment after air oxidation. (c) 1H enhancement vs B0 with
EPR pumping at a constant frequency of 140 MHz with 24
W of power. 1H NMR detection was performed on resonance.
Aqueous solutions of HPHT 18 nm (blue) and HPHT 125
nm (yellow) at 50 mg·mL−1 concentration were used. Solid
lines are included as a guide to the eye. (d) T1 relaxation
times of ND solutions at 6.5 mT. Solid lines are a fit to the
concentration dependent relaxivity equation. Arrow indicates
the change in relaxivity after air oxidation. The T1 relaxiv-
ity coefficients are 4.5×10−2 mL·s−1·mg−1 for HPHT 18 nm
(blue), 1.9×10−2 mL·s−1·mg−1 for HPHT 125 nm (yellow),
5.2×10−2 mL·s−1·mg−1 for NAT 125 nm (green), 1.0×10−1
mL·s−1·mg−1 for DET (red) and 2.3×10−1 mL·s−1·mg−1 for
air oxidized HPHT 18 nm (orange).
To demonstrate that NDs can be detected via the
Overhauser effect at ULF, we set B0 = 6.5 mT and apply
an RF magnetic field at the EPR frequency of 190 MHz
to a HPHT 125 nm, 100 mg·mL−1 sample. The 1H sig-
nal from the water surrounding the ND is then detected
through standard inductive NMR techniques after the
1H system has reached equilibrium [see methods]. Under
these conditions we observe an enhancement of -4.0 in
the 1H spin polarization when EPR power is applied, as
shown in Fig. 2(a).
Examining the enhancement produced by different
types of ND, Fig. 2(b) shows the sensitivity of the tech-
nique to nanoparticle concentration. We draw attention
to the data for the HPHT 18 nm NDs, which indicates
that at concentrations of 1 mg·mL−1, a 33 % change
in polarization can be observed. Natural NDs produce
a relatively small enhancement, probably due to a rela-
tively low concentration of paramagnetic defects, as seen
in their EPR spectra [see Fig. S1(c) for spectra].
Having demonstrated that Overhauser enhancement is
possible with ND, we return to Eq. 1 to further con-
sider the conditions needed for optimal imaging. The
saturation factor s describes the proportion of the EPR
linewidth that is driven and takes a maximum value of 1
when the electron transitions are completely saturated at
high RF power. To measure the EPR linewidth at ULF
we sweep B0 while driving electron transitions at 140
MHz. As shown in Fig. 2(c), HPHT 18 nm and HPHT
125 nm solutions show a linewidth for the enhancement
of ∼ 0.3 mT at a frequency consistent with the gyromag-
netic ratio of a free electron. This result indicates that
the paramagnetic centers responsible for the Overhauser
effect can be saturated with an ac field, B1e, of 1 mT,
which is easily achieved in our spectroscopic probe [39].
Finally, the remaining parameter in Eq. 1 is the leak-
age factor f which describes how effectively electrons
relax the nuclear spin environment, taking a maximum
value of 1 when all nuclear spin relaxation is via param-
agnetic centers. Measuring the spin relaxation time T1 of
1H spins in ND solutions (without applying EPR power)
provides a means of characterizing f in these systems,
as shown in Fig 2(d). We note that ND solutions with
shorter T1, and hence larger f , do not necessarily give
a higher Overhauser enhancement. For example, NAT
125 nm NDs show a T1 relaxivity more than double that
of HPHT 125 nm NDs, despite showing a much smaller
enhancement in Fig. 2(b). Presumably, ρ is suppressed
in the quasistatic nanophase by slow diffusion of water
molecules and the increased paramagnetic nuclear relax-
ation rate [40]. 1H nuclei ‘trapped’ in the nanophase will
experience rapid spin-lattice relaxation, giving the f we
observe and an overall enhancement that depends on the
specifics of each ND surface.
Solutions prepared with air oxidized ND consistently
exhibit reduced enhancements and higher T1 relaxivity,
as shown for 18 nm HPHT air oxidized NDs in Figs.
2(b) and 2(d). The increased nuclear spin-lattice relax-
ation rate will contribute to a reduction in Overhauser
enhancement and we speculate that the enhancement is
further reduced due to a lower concentration of param-
agnetic centers after removal of surface impurities by air
oxidation.
4OVERHAUSER MRI WITH NANODIAMOND
With the conditions that lead to near optimal Over-
hauser enhancement now established, we turn to demon-
strate that this approach can indeed be used as the ba-
sis for detecting ND solutions using ultra-low field MRI.
Imaging is performed using a custom proton-electron,
double resonant probe in an open-access, low-field, hu-
man MRI scanner operating at a B0 of 6.5 mT [41]. To
display the MRI contrast possible between a ND solution
and water we make use of the phantom illustrated in Fig.
3(a), which consists of glass vials filled with 500 µL of
either DI water or aqueous solutions of HPHT 125 nm
ND at 100 mg·mL−1 and organized in a diamond-shaped
pattern.
To overcome the low sensitivity of MRI at ultra-low
field, the phantom is imaged with a conventional 2D b-
SSFP (balanced steady state free precession) MRI se-
quence in which 1/3 of the imaging time is spent acquir-
ing signal [see methods for details] [42]. Although good
spatial resolution is achieved, no discernible contrast is
evident between ND solution vials and water vials, as
shown in Fig. 3(b). This is not surprising given that
contrast using the b-SSFP sequence is produced via 1H
concentration and the ratio T2/T1, which are approxi-
mately equal for all vials in the phantom [see Fig. 2(d)
for T1 and Fig. S1(b) for T2]. We note that obtaining
contrast with b-SSFP at ULF is usually challenging, as
when B0 → 0, it is a general result that T2/T1 → 1 [43].
The phantom is then imaged with a 2D OMRI b-SSFP
sequence, as shown in Fig. 3(c). The OMRI b-SSFP
sequence is equivalent to the regular b--SSFP sequence
except the EPR transition of the ND solution is driven
during the phase encode period [23]. The appearance
of water vials in the OMRI b-SSFP image is unchanged
from the regular b-SSFP image. However, the ND so-
lutions demonstrate significant relative contrast, with a
change in magnitude and inversion of signal phase, as a
result of the negative enhancement from the Overhauser
effect.
The switchable nature of the Overhauser contrast al-
lows us to take the difference of the signal in MRI
and OMRI images to generate the image in Fig. 3(d).
Such a difference image suppresses the background sig-
nal, clearly showing the spatial distribution of NDs. For
this difference image we calculate a contrast to noise ra-
tio (CNR) of ∼ 30, with the OMRI scan comprising 80
averages, taking 3 min 40 s to complete.
Having shown the feasilibity of ND imaging with
OMRI, we can derive the concentration sensitivity limit
of the technique from the magnitude of the Overhauser
effect and the MRI sensitivity in our setup. Images in
Fig. 3 were acquired with 1.5 mg ND per pixel. Assum-
ing a minimum detectable CNR of 2, the magnitude of
the Overhauser effect must be 7% of that used in Fig.
3. Our measurements indicate that, under this criteria,
HPHT 18 nm NDs should be still detectable at concen-
trations of 1 mg·mL−1 (see Fig. 2(a)). This sets a lower
FIG. 3. ND imaging with Overhauser MRI (OMRI) at 6.5
mT. (a) Imaging phantom. Vials of DI water (blue) and
vials of HPHT 125 nm ND at 100 mg·mL−1 (orange) were
arranged in the pattern shown. (b) Standard b-SSFP MRI
of the phantom shown in a. (c) OMRI b-SSFP image of the
same phantom. The Overhauser effect generates contrast be-
tween ND solution and water. The phase of the acquired
signal is inverted in the ND solution. (d) The difference of
MRI and OMRI acquisitions. The background signal is sup-
pressed, showing signal only where ND is present.
limit for detection of 15 µg of ND per pixel, or a particle
molar sensitivity of 150 nM. We note that this particle
mass sensitivity is equivalent to that reported for other
hyperpolarized MRI particle imaging modalities [16].
DISCUSSION AND CONCLUSION
NDs are non-toxic at high concentrations and resist in
vivo degradation for periods of over a month [44]. Thus,
the results presented here illustrate the potential of nan-
odiamond OMRI as a practical methodology for long-
term biological imaging providing new types of contrast
5and functionality. All imaging was performed on systems
designed for in vivo OMRI with RF powers acceptable for
use in vivo [45], raising the possibility of several excit-
ing biological applications, for example, in the accurate
detection of lymph node tumors, which is vital to the
treatment of metastatic prostate cancer [6]. Given that
nanoparticles ∼ 25 nm in size are known to preferentially
accumulate only in healthy lymphatic tissue, the ability
to detect and image ND in vivo may enable isolation of
the disease [2]. OMRI using NDs of selective size ranges
could also allow targeted probing of the permeability of
the blood brain barrier, giving a quantifiable measure of
disruption in the acute stage of ischemic stroke [46].
Finally, we remark that surface functionalization could
be used to tailor the Overhauser contribution produced
by the ND. In this way therapeutic agents attached to the
surface could suppress the Overhauser effect by increas-
ing the distance between radicals at their surface and
free water, leaving them ‘dark’ in OMRI scans. After
targeted drug release, the Overhauser effect could return
to normal, showing up ‘bright’ with OMRI and enabling
effective tracking of the site of drug delivery. The OMRI
approach may also enable the hyperpolarization of flu-
ids flowing across the surface of diamond nanostructures
[47–49].
In conclusion, we have used recent advances in ULF
MRI to extend the usefulness of OMRI to nanoparticle
imaging. The ability to noninvasively image biocompat-
ible NDs with switchable contrast at biologically rele-
vant concentrations is promising for a range of diagnos-
tic applications. Switchable contrast allows suppression
of the background signal present in other T1 and T2 based
nanoparticle MRI modalities [17, 50, 51]. Furthermore,
the long term biological stability of nanodiamonds in
vivo, as well as the unlimited repeatability of the hyper-
polarization sequence, raises the possibility of imaging
metabolic processes over dramatically longer timescales
than is possible with ex situ hyperpolarization techniques
[13, 16].
MATERIALS AND METHODS
Spectroscopic measurements at 6.5 mT. The 1H
enhancement of ND solutions was measured by saturat-
ing the EPR transition at 190 MHz for a period of 5T1
using 31 W of RF power before a standard NMR FID
acquisition. The magnitude of the hyperpolarized FID
is compared to an FID taken at thermal equilibrium. A
high filling factor Alderman-Grant Resonator was used
for EPR with an orthogonal solenoid used for NMR de-
tection. T1 relaxation times were measured using a con-
ventional inversion recovery acquisition.
Overhauser MRI. Imaging was performed at 6.5 mT
in our ultra-low field MRI scanner [41] using a b-SSFP
Overhauser-enhanced MRI (OMRI) sequence at room
temperature [23]. A homebuilt imaging probe was con-
structed from an Alderman-Grant resonator (EPR: 190
MHz) and a solenoid (1H: 276 kHz). The EPR resonator
was pulsed on during the phase encode steps, with 62 W
delivered to the EPR resonator at a duty cycle of 52%.
Gradient strength was a maximum of 1 mT·m−1. Images
in Fig. 3 were acquired with a 256 x 40 matrix size and
cropped. Data was acquired in 2D with a pixel size of
1.0 mm x 0.76 mm over a 30 mm x 30 mm field of view
and interpolated onto 0.25 mm x 0.19 mm pixels. The
phantom thickness was 20 mm. The standard MRI was
acquired with 200 averages (9 minutes) and the OMRI
image with 80 averages (3 minutes 40 seconds). Image
magnitude was scaled for an accurate comparison.
Nanodiamond Solution Preparation. NDs used
in this study were sourced from Microdiamant, Switzer-
land. Nanodiamond types used were; monocrystalline,
synthetic HPHT NDs in 18 nm (0-30 nm, median diame-
ter 18 nm) and 125 nm (0-250 nm, median diameter 125
nm) sizes; monocrystalline, 125 nm NAT NDs (0-250 nm,
median diameter 125 nm); and polycrystalline DET ND
(Cluster size 250-1000 nm, median 500 nm. Individual
particle size 4-8 nm). Size specifications were provided
by the manufacturer. Air oxidized NDs were prepared by
placing them in a furnace at standard pressure for one
hour at 550 ◦C after an initial temperature ramp [24].
ND samples were mixed with DI water and sonicated
with a Branson probe sonicator at 120 W and 50% duty
cycle for 40 minutes to disaggregate ND clusters.
Particle size and zeta potential measurements were
performed on ND solutions in a Beckman Coulter Delsa
Nano C Particle Analyzer. Particle size measurements
confirmed that monocrystalline NDs were well dispersed
in water after sonication. Particle sizes of monocrys-
talline NDs were found to be consistent with manu-
facturer specifications. DET NDs still displayed some
clustering and inconsistent particle size in solution after
probe sonication.
DNP Linewidth Measurements - B0 Field
Sweep. The linewidth of the Overhauser effect was stud-
ied by measuring the 1H enhancement at various mag-
netic field strengths whilst driving the EPR resonator
at a frequency of 140 MHz and 25 W. The EPR fre-
quency was lowered from 190 MHz in order to capture
the enhancement profile either side of the peak without
exceeding the maximum field accessible in our ULF mag-
net. 1H enhancement was measured as the magnetic field
was stepped between 4 mT and 7 mT. NMR detection
was performed at the 1H resonance for any given field
strength, with a low Q solenoidal coil.
EPR Measurements. CW EPR measurements were
performed on 100 mg·mL−1 ND samples in a Bruker
ElexSys E500 EPR system. Modulation frequency was
100 kHz at an amplitude of 0.1 G and incident mi-
crowave power of 0.6725 mW. Sample volumes in the
cavity were kept consistent to allow comparison of rel-
ative peak heights. Individual EPR components were
simulated in EasySpin [30] and a least squares analysis
was used to find the best fit to the data while varying
g-factor, linewidth and amplitude.
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